Published in Lab Law Weekly, December 16th, 2005
The settlement came after a recent favorable ruling by the United States Court of Appeals for the Federal Circuit relating to Transonic's United States Patent No. 5,685,989 (the Krivitski patent) on the indicator dilution, blood line reversal approach to measure access flow...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.